codice protocollo
AFT-38 PATINAA Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti- HER2 Therapy + Endocrine Therapy vs. Anti- HER2 Therapy + Endocrine Therapy after induction Treatment for Hormone Receptor Positive (HR+)/HER2- Positive Metastatic Breast Cancer. (AFT-38 PATINA)
data di chiusura
domenica 31 maggio 2020sperimentatore principale
Claudia Andreetta
struttura
Dipartimento di Oncologia Udine
allegati